C43-C44

Melanoma and other malignant neoplasms of skin

This block represents a critical clinical grouping of cutaneous malignancies, primarily differentiating between malignant melanoma (C43) and other non-melanoma skin cancers (C44), such as basal cell carcinoma (BCC) and squamous cell carcinoma (SCC). Malignant melanoma is the most aggressive form of skin cancer, originating from melanocytes, and has a high potential for metastasis if not detected early. Non-melanoma skin cancers (NMSC), which comprise the majority of skin cancer diagnoses, typically arise from keratinocytes in the basal or squamous layers of the epidermis. While NMSCs are generally less likely to metastasize than melanoma, they can be locally invasive and cause significant tissue destruction. The classification system differentiates these neoplasms based on histological type and anatomical location, which are vital for determining surgical margins, the necessity of sentinel lymph node biopsy, and systemic therapy options.

Clinical Symptoms

  • Asymmetry in a mole or skin lesion
  • Irregular, notched, or blurred borders
  • Variations in color (shades of brown, black, red, white, or blue)
  • Diameter larger than 6 millimeters
  • Evolution or change in size, shape, or color of an existing lesion
  • Persistent itching or tenderness in a skin spot
  • Pearly or waxy bumps on the skin (characteristic of basal cell carcinoma)
  • Flat, flesh-colored or brown scar-like lesions
  • Firm, red nodules (characteristic of squamous cell carcinoma)
  • Non-healing sores or ulcers that bleed or crust
  • Scaling or bleeding of a mole

Common Causes

  • Excessive exposure to ultraviolet (UV) radiation from sunlight
  • Use of indoor tanning beds and sunlamps
  • Fair skin type (Fitzpatrick scale I-II) with low melanin protection
  • History of blistering sunburns, especially during childhood or adolescence
  • Genetic mutations, including CDKN2A and BRAF mutations
  • Immunosuppression (e.g., organ transplant recipients, HIV/AIDS)
  • Presence of multiple atypical or dysplastic nevi
  • Family or personal history of skin malignancies
  • Exposure to environmental carcinogens such as arsenic
  • Chronic skin inflammation or long-term scarring (Marjolin's ulcer)
  • Inherited conditions such as xeroderma pigmentosum

Documentation & Coding Tips

Document specific anatomical site and laterality for all skin malignancies.

Example: Patient presents for wide local excision of biopsy-confirmed malignant melanoma of the skin of the right upper eyelid, Breslow depth 0.8 mm. Site is clearly identified on the right side. Procedure is indicated for primary malignancy C43.111. History includes personal history of malignant melanoma of the trunk (Z85.820).

Billing Focus: Laterality and specific eyelid location (upper vs lower) are required to map to the seventh character in C43.1- and C44.1- series.

Include Breslow depth and Clark level for melanoma to support staging and severity.

Example: Final pathology for the lesion on the left malar cheek indicates a nodular melanoma, Breslow depth 2.1 mm, Clark level IV, with no ulceration. Staged as pT3a. Documentation supports C43.39 for melanoma of other parts of face.

Billing Focus: While depth is not always a code-driver for the ICD-10 code itself, it justifies the complexity of E/M coding and the use of more intensive surgical codes like Mohs.

Differentiate between primary, recurrent, and metastatic lesions.

Example: The patient has a recurrent basal cell carcinoma of the skin of the nose, previously treated with cryotherapy. Examination shows a 1.5 cm pearly papule at the prior scar site. Coded as C44.311 for basal cell carcinoma of skin of nose. Patient also has concurrent chronic obstructive pulmonary disease (J44.9) which increases surgical risk.

Billing Focus: Recurrence must still be coded as a current malignancy if the disease is active; do not use history codes for active recurrences.

Identify the specific histological type for non-melanoma skin cancers.

Example: Biopsy of the left dorsal hand lesion reveals squamous cell carcinoma in situ. Documented as D04.62. If the lesion were invasive, it would be C44.622. Patient currently on long-term systemic anticoagulation (Z79.01) for atrial fibrillation.

Billing Focus: Clarity between in situ (D04) and invasive (C44) is mandatory to prevent upcoding or downcoding errors.

Document presence of perineural or lymphovascular invasion in pathology summaries.

Example: Squamous cell carcinoma of the skin of the right ear (C44.222), with evidence of perineural invasion noted on Mohs stage 2. Patient has history of actinic keratosis (L57.0) and chronic kidney disease stage 3 (N18.30).

Billing Focus: Perineural invasion justifies higher complexity for surgical reconstruction codes and complex closures (13100-13153).

Relevant CPT Codes

Related Diagnoses

Hierarchy